Search results
Results from the WOW.Com Content Network
Even with that growth, the stock still trades at a fairly modest valuation. Its stock price is up 5.3% this year, compared with 16% growth for the S&P 500. Why isn't Merck's stock doing better in ...
The Walt Disney Company: DOW The Dow Chemical Company: GE General Electric Company: HPQ Hewlett-Packard Company: IBM International Business Machines Corporation: JNJ Johnson & Johnson: JPM JPMorgan Chase & Co. KO The Coca-Cola Company: MCD McDonald's Corp. MMM 3M Company: MRK Merck & Co. Inc. MSFT Microsoft Corporation: PG The Procter & Gamble ...
On Monday, Merck & Co Inc (NYSE:MRK) revealed topline results from the Phase 3 ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with pulmonary arterial hypertension (PAH, WHO Group 1 ...
Merck is forecasting 2024 revenue to climb by 5% to 7% over the 2023 result, while its earnings-per-share (EPS) target of $7.94 to $8.04 represent a midpoint increase of 7% from the company record ...
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of which it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The next few years might get bumpy for the pharmaceutical giant, but the longer term looks better.
For premium support please call: 800-290-4726 more ways to reach us